The Role of Vaccines in Antimicrobial Stewardship Program to Reduce Resistance
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: closed (31 January 2021) | Viewed by 652
Special Issue Editor
2. Clinica Malattie Infettive, Ospedale Policlinico San Martino–IRCCS, 16132 Genoa, Italy
Interests: antimicrobial resistance; new antibiotics; critically ill patients; pneumonia; influenza
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
antimicrobial resistance (AMR) represents an emerging threat to global health, tipically associated with high morbidity and mortality rate. According to a recent English report, if AMR is not controlled, 10 million people will die of drug-resistant bacterial infections annually in 2050 worldwide, with a cumulative economic loss reaching $100 trillion.
The World Health Organization (WHO) has formulated global action plans to reduce the widespreade rise of AMR, including a number of well-established interventions such as sanitation and hygiene, funding mechanisms to develop new classes of antibiotics and education to avoid inappropriate antibiotic use. Antimicrobial stewardship programmes has also been formulated as a way to optimize the use of antimicrobials while preventing the development of resistance and improving patient outcomes. Such programmes are made up of several core elements including new diagnostic tecnologies or educational programs aimed to avoid overuse, misuse, or abuse of antibiotics.
Despite vaccines are in a phase of major improvements and technological advances on many fronts, few attention has been paid to vaccines as a new element of antimicrobial stewardship programmes, yet the positive effect in reducing AMR has been well established. Therefore, the objective of this special issue is to look at how vaccines may be used in the fight against AMR, both directly, by reducing the incidence of bacterial infections, and indirectly, by the multiple ways in which they can reduce the use of antibiotics.
Prof. Dr. Matteo Bassetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- influenza
- Streptococcus pneumoniae
- Haemophilus influenzae
- antimicrobial stewardship
- antibiotic consuption
